Ethosome formulations of known contact allergens can increase their sensitizing capacity

Acta Dermato-Venereologica

Volumn 90, Issue 4, 2010, Pages 374-378

  Madsen, Jakob Torp ^a   Vogel, Stefan ^b   Karlberg, Ann Therese ^c   Simonsson, Carl ^c   Johansen, Jeanne Duus ^d   Andersen, Klaus E ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Contact dermatitis; Ethosomes; Liposomes; Local lymph node assay; Skin sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CONTACT ALLERGEN; COSMETIC; DRUG CARRIER; ETHOSOME; ISOEUGENOL; LIPOSOME; UNCLASSIFIED DRUG; ALLERGEN; EUGENOL;

ALLERGENICITY; ARTICLE; BIOAVAILABILITY; CONTACT ALLERGY; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LOCAL LYMPH NODE ASSAY; PRIORITY JOURNAL; SENSITIZATION; ANALOGS AND DERIVATIVES; ANIMAL; CBA MOUSE; CELL PROLIFERATION; DERMATITIS, ALLERGIC CONTACT; DOSE RESPONSE; DRUG EFFECTS; DRUG FORMULATION; FEMALE; IMMUNIZATION; IMMUNOLOGY; LYMPH NODE; MEDICINAL CHEMISTRY; MOUSE; PARTICLE SIZE; PATHOLOGY;

ALLERGENS; ANIMALS; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; DERMATITIS, ALLERGIC CONTACT; DINITROCHLOROBENZENE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; EUGENOL; FEMALE; IMMUNIZATION; LIPOSOMES; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; MICE, INBRED CBA; PARTICLE SIZE;

EID: 77954918336     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0874     Document Type: Article

References (29)

1. Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 700-705.
2. Lakshmi P, Devi G, Bhaskaran S, Sacchidanand S. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol 2007; 73: 157-161. (Pubitemid 46918508)
3. de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J Eur Acad Dermatol Venereol 2009; 23: 505-516.
4. Jain S, Umamaheshwari R, Bhadra D, Jain N. Ethosomes: a novel vesicular carries for enhanced transdermal delivery of an anti HIV agent. Indian J Pharm Sci 2004; 66: 72-81.
5. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000; 21: 1879-1885. (Pubitemid 30398506)
6. Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother 2005; 55: 989-994. (Pubitemid 40883186)
7. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, LeviSchaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001; 22: 3053-3059. (Pubitemid 32768713)
8. Kaplun-Frischoff Y, Touitou E. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci 1997; 86: 1394-1399. (Pubitemid 28018321)
9. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004; 94: 365-379. (Pubitemid 38117147)
10. Marston S. Propyl gallate on liposomes. Contact Derm 1992; 27: 74-76.
11. Clemmensen A, Thormann J, Andersen KE. Allergic contact dermatitis from retinyl palmitate in polycaprolactone. Contact Derm 2007; 56: 288-289. (Pubitemid 46624109)
12. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharmaceut 2003; 258: 141-151. (Pubitemid 36712878)
13. Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005; 18: 209-219. (Pubitemid 41159952)
14. Choi MJ, Maibach HI. Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci 2005; 27: 211-221.
15. Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Del Rev 2002; 54: S41-S55.
16. El Maghraby GM, Williams AC, Barry BW. Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 2006; 58: 415-429.
17. Andersen KE, Carlsen L, Egsgaard H, Larsen E. Contact sensitivity and bioavailability of chlorocresol. Contact Derm 1985; 13: 246-251.
18. Basketter DA, Gerberick GF, Kimber I. Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem Toxicol 2001; 39: 621-627. (Pubitemid 32429476)
19. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000; 65: 403-418. (Pubitemid 30122942)
20. Organisation for Economic Co-operation and Development (OECD). Guideline for the testing of chemicals: (Part 429). OECD; Paris, France, 2002.
21. Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, et al. The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target 1995; 3: 301-310. (Pubitemid 26032032)
22. Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay. Cutan Ocul Toxicol 2008; 67-75. (Pubitemid 351883401)
23. Heylings JR, Clowes HM, Cumberbatch M, Dearman RJ, Fielding I, Hilton J, Kimber I. Sensitization to 2,4-dinitrochlorobenzene: influence of vehicle on absorption and lymph node activation. Toxicol 1996; 109: 57-65. (Pubitemid 26134790)
24. El Maghraby GM, Williams AC. Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 2009; 6: 149-163.
25. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007; 66: 159-164. (Pubitemid 46654773)
26. Schaefer H, Lademann J. The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 2001; 14 Suppl 1: 23-27.
27. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol 2001; 14 Suppl 1: 72-81.
28. Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 2007; 37: 251-277. (Pubitemid 46440572)
29. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 2006; 322: 60-66.